The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of the bevacizumab pharmacokinetics with efficacy and toxicity in advanced non-squamous non-small cell lung cancer: Kumamoto Thoracic Oncology Study Group (KTOSG) 1003 study.
 
Sho Saeki
No Relationships to Disclose
 
Jiichiro Sasaki
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly Japan
Research Funding - Chugai Pharma; Lilly Japan
 
Shinya Sakata
No Relationships to Disclose
 
Ryo Sato
No Relationships to Disclose
 
Koichi Saruwatari
No Relationships to Disclose
 
Yasumiko Sakamoto
No Relationships to Disclose
 
Megumi Inaba
No Relationships to Disclose
 
Hiroto Kishi
No Relationships to Disclose
 
Shinji Fujii
No Relationships to Disclose
 
Shinsuke Tsumura
No Relationships to Disclose
 
Mayu Ouchi
No Relationships to Disclose
 
Hideyuki Saito
No Relationships to Disclose
 
Akinobu Hamada
No Relationships to Disclose
 
Hirotsugu Kohrogi
No Relationships to Disclose